A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors | MicrobiomeTrials← Back to trialsNCT07205718
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-11-19Est. Completion: 2028-12-26
Enrollment target: 223 participants Locations- UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica), Santa Monica, California, United States
- Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers, New Haven, Connecticut, United States
- Florida Cancer Specialists - Lake Nona, Orlando, Florida, United States
- Johns Hopkins, Baltimore, Maryland, United States
- Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
- START Midwest, Grand Rapids, Michigan, United States
- Washington University, St Louis, Missouri, United States
- University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
- Providence Cancer Institute, Franz Clinic, Portland, Oregon, United States
- Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
- SCRI Oncology, Nashville, Tennessee, United States
- MD Anderson Cancer Center, Houston, Texas, United States
- NEXT Dallas, Irving, Texas, United States
- START San Antonio, San Antonio, Texas, United States
- NEXT Virginia, Fairfax, Virginia, United States
Other microbiome trials you might be interested in
Advanced/Metastatic Non-Small Cell Lung Cancer
This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metas…
Goodyear, United StatesEst. completion Jun 24, 2030
Solid Tumor
This is a first-in-human (FIH), phase 1/2, multi center, open-label, dose escalation and cohort expansion study designed…
Huntersville, United StatesCompleted Apr 1, 2025
Phase 2
Recruiting
Advanced or Metastatic Ovarian Cancer
This is a Phase II, multicenter, single-arm dose expansion trial planned to enroll up to 30 subjects with advanced or me…
Guangzhou, ChinaEst. completion Nov 30, 2027